Erschienen in:
25.01.2016 | Kardiomyopathie | Review article
The MOGE(S) classification
A TNM-like classification for cardiomyopathies
verfasst von:
E. Şahan, M.D., S. Şahan, M.D., M. Karamanlıoğlu, M.D., M. Gul, M.D., O. Tufekcioğlu, Assoc. Prof. M.D.
Erschienen in:
Herz
|
Ausgabe 6/2016
Einloggen, um Zugang zu erhalten
Abstract
Cardiomyopathy is a disease of the heart muscle resulting from genetic defects, cardiac myocyte injury, or infiltration of the myocardium. Cardiomyopathies are traditionally defined as dilated, restrictive, and hypertrophic cardiomyopathy. Today, the genetic basis of most diseases has been clearly defined and has influenced the approach to familial diseases such as cardiomyopathies. Traditional definitions of cardiomyopathies, such as those by the American Heart Association and the European Society of Cardiology, do not consider the genetic basis of cardiomyopathies. In 2013, the World Heart Federation added the genetic basis of cardiomyopathies and proposed a descriptive genotype–phenotype nosology system termed “MOGE(S).” The MOGE(S) system resembles the TNM classification system for malignancy, and therefore it can be useful for the diagnosis, management, and treatment of cardiomyopathies in a similar manner to cancer management.